Companies / India
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
Venus Remedies Continues To Look For A Challenge
April 2008 | Company News AlertSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
Demonstrating its desire to compete in challenging pharmaceutical markets, India's Venus Remedies has received accreditation from the General Foreign Trade Organisation (GFTO) of Syria. Its manufacturing plant in Baddi, India, has been approved by the GFTO and exports will be routed to Syria through Venus' German subsidiary Venus Pharma GmbH. The arrangement will make use of Germany's strong trade links with Syria. According to the International Trade Centre, Germany was Syria's top pharmaceutical import partner in 2006 and accounted for more than 10% of pharmaceutical